- Home
- Media Center
- Press releases
- Financial
Financial
Investigational Darunavir-Based Single-Tablet Regimen Shows Positive Results in Previously Untreated HIV Patients in Pivotal Phase 3 AMBER Clinical Trial
AMBER 48-week safety and efficacy results to be presented at the 16th European AIDS Conference